Eli Lilly and Company vs. Teva Pharmaceuticals International GmbH et al.
Explore the PTAB proceeding IPR2018-01422 filed by Eli Lilly and Company on 2018-08-08. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2018-01422
Filing Date
2018-08-08
Accorded Filing Date
2018-08-23
Institution Decision Date
2019-02-19
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2020-02-18
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Eli Lilly and Company
Represented By
Raich, Williamet alPatent Owner / Respondent
Patent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 25351 | S Ludwig | +1 212-641-2320 |
| 30499 | Robert Sullivan Jr | +1 212-765-5070 |
| 31644 | P Musselman Jr | +1 214-292-4030 |
| 32983 | J Fasse | +1 617-542-5070 |
| 34609 | David Goren | +1 650-839-5070 |
| 34819 | Janis Fraser | +1 617-542-5070 |
| 35283 | Anita Meiklejohn | +1 617-542-5070 |
| 35322 | John Phillips | +1 858-678-5070 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 9,340,614 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 73,662,305 P | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2007054809 A2 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 9,363,808 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,586,045 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,597,649 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,734,802 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,115,194 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,328,168 B2 | US Continuation / Sibling | View Official Patent → |
Eli Lilly and Company v. Teva Pharmaceuticals International GmbH et al.
Eli Lilly and Company v. Teva Pharmaceuticals International GmbH et al.
Teva Pharmaceuticals International GmbH v. Eli Lilly and Company